Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
NVO
VRTX
Add up to 3 more stocks
NVO
Novo Nordisk A/S
+1.68%
$46.48+0.77At close: Aug 19, 2026, 4:00 PM ET
Market Cap
$206.40B
52W Range
$35.12 - $64.16
VRTX
Vertex Pharmaceuticals Incorporated
+4.52%
$552.06+23.87At close: Aug 19, 2026, 4:00 PM ET
Market Cap
$140.12B
52W Range
$374.17 - $553.69
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 11.45 | 32.13 |
| Forward P/E | N/A | 29.41 |
| P/B Ratio | 6.11 | 6.97 |
| P/S Ratio | 4.04 | 11.18 |
| P/FCF Ratio | 27.68 | 37.19 |
| EV/EBITDA | 8.42 | 26.91 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 80.6% | 86.0% |
| Operating Margin | 43.1% | 38.6% |
| Net Margin | 35.3% | 34.9% |
| ROE | 53.5% | 21.8% |
| ROA | 19.9% | 16.1% |
| ROIC | 30.2% | 17.3% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 0.87 | 3.19 |
| Quick Ratio | 0.66 | 2.74 |
| Debt/Equity | 0.63 | 0.10 |
| Interest Coverage | 30.34 | 357.95 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 1.3% | N/A |
| Payout Ratio | 16.1% | N/A |
| Yrs of Dividend Growth | 6 | 0 |
N/A includes metrics that are structurally not meaningful for a company's sector (e.g. EV multiples, free-cash-flow ratios, and working-capital ratios for banks and insurers). Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.